Overview
A one-year clinical fellowship in the multidisciplinary Amyloidosis Program of Calgary covering diagnosis, disease-modifying therapy and follow-up, with imaging, HF, haematology and neurology exposure.
The programme
- Focus
- Cardiac amyloidosis / cardiomyopathy
- Training type
- Clinical Fellowship
- Duration
- 1 year
- Start
- Not stated on official page
- Positions
- Not stated on official page
- Accreditation
- University of Calgary clinical fellowship (non-Royal College unless stated)
- Department
- Department of Cardiac Sciences, Cumming School of Medicine
Eligibility and visa
- Eligibility
- Successful completion of three years of general cardiology training
- International applicants
- Institution policyInternational medical graduates accepted as International Clinical Fellows or Sponsored Fellows if they hold a CPSA-acceptable medical degree, completed residency, verify credentials via physiciansapply.ca, meet CPSA English-language requirements and obtain a work permit; funding must come from a PGME-approved source
- Visa support
- Institution policyInternational fellows need an IRCC work permit valid for the whole fellowship; PGME supplies the LMIA-exemption number for the application and fellows cannot start (or enter Canada for training) without it
- Licence requirement
- Educational licence through the College of Physicians & Surgeons of Alberta (CPSA) arranged via PGME after acceptance
How to apply
- Deadline
- Not stated on official page
- Application method
- CV, one-page letter of interest and two reference letters to Samantha Hardy (samantha.hardy@ahs.ca)
Funding
- Funding
- Institution policyNo PGME funding; clinical fellows must be funded by a PGME-approved source (department/AHS/sponsoring government, hospital or university - no personal funds), with stipend at least equivalent to PGY1 under the Alberta Resident Physician Agreement